![](https://www.molecular-medicine-israel.co.il/wp-content/uploads/2017/10/gr1-246x300.jpg)
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling
Summary Androgen receptor (AR) signaling is a distinctive feature of prostate carcinoma (PC) and represents the major therapeutic target for treating metastatic prostate cancer (mPC).